Abiopharma

Clinical trial NCT06639607: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT07238816 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-04-29 → 2026-05-08 3. primary completion date: 2026-04-29 → 2026-05-08 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05724563 updates: 1. completion date: 2027-06-01 → 2028-06-01 2. primary completion date: 2026-07-01 → 2027-07-01

Clinical trial NCT07398378 updates: 1. status: NOT_YET_RECRUITING → ACTIVE_NOT_RECRUITING 2. start date: 2026-04-01 → 2026-06-12 3. completion date: 2026-06-01 → 2026-07-01 4. primary completion date: 2026-06-01 → 2026-07-01 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05852431 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-01 → 2026-04-09 3. enrollment: 360 → 369 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07525206 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-07 → 2026-05-22

Clinical trial NCT04905316 updates: 1. completion date: 2026-05-01 → 2027-05-01 2. primary completion date: 2026-05-01 → 2027-05-01

Clinical trial NCT04036682 updates: 1. completion date: 2026-03-31 → 2028-03-31 2. primary completion date: 2026-01-31 → 2025-10-13 3. collaborators added: Taiho Oncology, Inc.

Clinical trial NCT03132792 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-12-07 → 2025-11-19 3. enrollment: 45 → 39 participants

Clinical trial NCT07589595 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-05-20